Role of CFTR and ClC-5 in modulating vacuolar H+-ATPase activity in kidney proximal tubule.
OBJECTIVE
It has been widely accepted that chloride ions moving along chloride channels act to dissipate the electrical gradient established by the electrogenic transport of H(+) ions performed by H(+)-ATPase into subcellular vesicles. Largely known in intracellular compartments, this mechanism is also important at the plasma membrane of cells from various tissues, including kidney. The present work was performed to study the modulation of plasma membrane H(+)-ATPase by chloride channels, in particular, CFTR and ClC-5 in kidney proximal tubule.


RESULTS
Using in vivo stationary microperfusion, it was observed that ATPase-mediated HCO(3)(-) reabsorption was significantly reduced in the presence of the Cl(-) channels inhibitor NPPB. This effect was confirmed in vitro by measuring the cell pH recovery rates after a NH(4)Cl pulse in immortalized rat renal proximal tubule cells, IRPTC. In these cells, even after abolishing the membrane potential with valinomycin, ATPase activity was seen to be still dependent on Cl(-). siRNA-mediated CFTR channels and ClC-5 chloride-proton exchanger knockdown significantly reduced H(+)-ATPase activity and V-ATPase B2 subunit expression.


CONCLUSIONS
These results indicate a role of chloride in modulating plasma membrane H(+)-ATPase activity in proximal tubule and suggest that both CFTR and ClC-5 modulate ATPase activity.
Department of Physiology and Biophysics, University of São Paulo, São Paulo, Brazil.
Luciene R
LR
Carraro-Lacroix
Lucília M A
LM
Lessa
Camila N A
CN
Bezerra
Thaíssa D
TD
Pessoa
Jackson
J
Souza-Menezes
Marcelo M
MM
Morales
Adriana C C
AC
Girardi
Gerhard
G
Malnic
D000643:Ammonium Chloride / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001639:Bicarbonates / Q000378:metabolism; D002460:Cell Line; D018118:Chloride Channels / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D007687:Kidney Tubules, Proximal / Q000201:enzymology*; D009579:Nitrobenzoates / Q000494:pharmacology; D034622:RNA Interference; D034741:RNA, Small Interfering; D051381:Rats; D025262:Vacuolar Proton-Translocating ATPases / Q000378:metabolism*; D014634:Valinomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001639:Bicarbonates; C097503:CLC-5 chloride channel; D018118:Chloride Channels; D009579:Nitrobenzoates; D034741:RNA, Small Interfering; D000643:Ammonium Chloride; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D014634:Valinomycin; C058176:5-nitro-2-(3-phenylpropylamino)benzoic acid; D025262:Vacuolar Proton-Translocating ATPases